FY2024 Earnings Estimate for Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Issued By Brookline Capital Management

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) – Research analysts at Brookline Capital Management dropped their FY2024 earnings estimates for shares of Bioceres Crop Solutions in a research report issued on Tuesday, November 14th. Brookline Capital Management analyst K. Dolliver now anticipates that the company will post earnings of $0.84 per share for the year, down from their previous estimate of $0.97. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.65 per share. Brookline Capital Management also issued estimates for Bioceres Crop Solutions’ Q4 2024 earnings at $0.44 EPS.

BIOX has been the subject of several other reports. Lake Street Capital decreased their price target on shares of Bioceres Crop Solutions from $30.00 to $25.00 and set a “buy” rating for the company in a report on Tuesday, September 12th. Roth Mkm reduced their target price on shares of Bioceres Crop Solutions from $31.00 to $20.00 and set a “buy” rating for the company in a research note on Wednesday, November 1st.

Bioceres Crop Solutions Trading Up 3.3 %

NASDAQ BIOX opened at $11.74 on Friday. Bioceres Crop Solutions has a one year low of $9.76 and a one year high of $14.20. The company has a 50-day simple moving average of $10.88 and a 200-day simple moving average of $11.71. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.86 and a current ratio of 1.33. The firm has a market capitalization of $737.24 million, a PE ratio of 65.22 and a beta of 0.45.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings results on Monday, September 11th. The company reported ($0.06) EPS for the quarter, missing the consensus estimate of $0.04 by ($0.10). Bioceres Crop Solutions had a net margin of 2.71% and a return on equity of 3.42%. The business had revenue of $104.70 million during the quarter, compared to analyst estimates of $96.59 million. During the same period last year, the firm posted ($0.12) earnings per share.

Institutional Trading of Bioceres Crop Solutions

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Ardsley Advisory Partners LP raised its position in shares of Bioceres Crop Solutions by 4.8% during the 1st quarter. Ardsley Advisory Partners LP now owns 1,942,650 shares of the company’s stock worth $22,554,000 after buying an additional 88,650 shares in the last quarter. Uniplan Investment Counsel Inc. raised its holdings in shares of Bioceres Crop Solutions by 9.4% in the 1st quarter. Uniplan Investment Counsel Inc. now owns 471,924 shares of the company’s stock worth $5,479,000 after purchasing an additional 40,584 shares in the last quarter. Wellington Management Group LLP raised its holdings in shares of Bioceres Crop Solutions by 5.4% in the 1st quarter. Wellington Management Group LLP now owns 232,588 shares of the company’s stock worth $2,700,000 after purchasing an additional 11,892 shares in the last quarter. Ballast Asset Management LP bought a new stake in shares of Bioceres Crop Solutions in the 3rd quarter worth approximately $2,210,000. Finally, Royce & Associates LP raised its holdings in shares of Bioceres Crop Solutions by 35.3% in the 2nd quarter. Royce & Associates LP now owns 180,000 shares of the company’s stock worth $2,405,000 after purchasing an additional 47,000 shares in the last quarter. 13.35% of the stock is currently owned by institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. The firm includes seeds, seed traits, seed treatments, biologicals, high-value adjuvants and fertilizers. It operates through the following segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition.